q-bio.TONov 9, 2026

Clinical predictions using artificial intelligence in neurosurgery and its subspecialties: a systematic review and meta-analysis

Authors: Prajwal Ghimire, Aswin Chari, Jonathan Shapey, Keyoumars Ashkan

Organizations: Department of Neurosurgery, King’s College Hospital NHS Foundation Trust, London, UK · School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK · King’s Institute of Artificial Intelligence, King’s College London, London, UK · Department of Neurosurgery, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK · 

Abstract

Artificial intelligence models for clinical prediction are proliferating across neurosurgery, but their aggregate discriminative performance, distribution along the care pathway and methodological quality are unclear. We systematically reviewed and meta-analysed these studies in neurosurgery and its subspecialities along with their risk of bias appraisal. We performed a PRISMA search for peer-reviewed original studies using AI to predict a clinical outcome in neurosurgical populations. Metrics were pooled using random effects modelling. Each study was classified as diagnostic, prognostic or forecasting and was assigned an evidence level. Clinical prediction task sub-stratification analysis was performed. Risk-of-bias was assessed using PROBAST. 1063 studies were included. Across 451 studies reporting AUC, pooled discrimination was 0.86, ranging from 0.84 (spine) to 0.87 (neuro-oncology), with extreme heterogeneity. Performance varied by clinical pathway stage, highest for diagnosis, grading and molecular tasks and lowest for post-operative tasks. Only 51 studies were using prospective data with external validation, whereas 619 rested on internal validation alone or no validation. 89 percent studies were at high risk-of-bias, driven by the analysis domain. AI models report high performance across all the neurosurgical subspecialities, concordant across AUC, accuracy, sensitivity and specificity and robust to risk-of-bias stratification. Performance is highest for imaging-anchored diagnostic tasks and lowest at decision-facing post-operative stage. However, the literature is dominated by optimism-prone, internally-validated and poorly calibrated models with extreme heterogeneity. External validation, calibration analysis and reporting guidelines adherence remain prerequisites for clinical adoption.

Explore similar work

Mar 28, 2026

A Comparative Study in Surgical AI: Potential and Limitations of Data, Compute, and Scaling

Recent Artificial Intelligence (AI) models have matched or exceeded human experts in several benchmarks of biomedical task performance, but surgical benchmarks in particular are often missing from prominent medical benchmark suites. Since surgery requires integrating disparate tasks, generally-capable AI models could be particularly attractive as a collaborative tool if performance could be improved. On the one hand, the canonical approach of scaling architecture size and training data is attractive, especially since there are millions of hours of surgical video data generated per year. On the other hand, preparing surgical data for AI training requires significantly higher levels of professional expertise, and training on that data requires expensive computational resources. These trade-offs paint an uncertain picture of whether and to-what-extent modern AI could aid surgical practice. In this paper, we explore this question through a case study of surgical tool detection using state-of-the-art AI methods available in 2026. We demonstrate that even with multi-billion parameter models and extensive training, current Vision Language Models fall short in the seemingly simple task of tool detection in neurosurgery. Additionally, we show scaling experiments indicating that increasing model size and training time only leads to diminishing improvements in relevant performance metrics. Thus, our experiments suggest that current models could still face significant obstacles in surgical use cases. Moreover, some obstacles cannot be simply ``scaled away'' with additional compute and persist across diverse model architectures, raising the question of whether data and label availability are the only limiting factors. We discuss the main contributors to these constraints and advance potential solutions.
Mar 30, 2026

Prompts Without Evidence: How Neuroimaging Mentions Shift Clinical Vision-Language Model Predictions

Trustworthy clinical AI must use real evidence and avoid relying on surface-level artifacts. We evaluate 12 open-weight vision-language models (VLMs) on two clinical neuroimaging cohorts for binary classification of affective disorders and cognitive decline. Both cohorts include structural magnetic resonance imaging (MRI) acquired under their original research protocols. Prior work does not establish the included neuroimaging inputs as reliable stand-alone diagnostic evidence for the present tasks. Nevertheless, when neuroimaging context is introduced, smaller VLMs gain up to 0.66 F1 under the evaluated augmented conditions, becoming competitive with models an order of magnitude larger. Confidence estimation shows that most of the calibration improvement for the analyzed smaller models occurs after the MRI reference is added to the prompt, before any image is supplied. Our preliminary expert case study finds that faithfulness remains low in every condition examined, with the reviewed model introducing unverified clinical details. Finally, in our single-model intervention, preference alignment suppresses MRI-referencing behavior but reduces the augmented-condition advantage, leaving the underlying issue unresolved. These results caution against reading surface metric gains as evidence of true multimodal integration, with direct implications for clinical VLM deployment.
Nov 3, 2026

Fairness Metrics based on the AUC in Clinical Predictive AI

Fairness evaluation of clinical prediction models for binary outcomes often involves fairness metrics that compare the area under the receiver operating characteristic curve (AUC, or c-statistic) across subgroups. However, the AUC has been shown to be a non-collapsible metric, meaning that its subgroup specific and overall values are not directly comparable as often implicitly assumed. This raises important questions about how existing AUC-based fairness metrics should be used and interpreted. We examine eight AUC-based fairness metrics proposed in the literature, including: within-group AUC parity; cross-group AUC (xAUC) parity; gap-to-overall AUC; equity-scaled AUC; minimum-based metrics; xAUC1\mathrm{xAUC}^1; xAUC0\mathrm{xAUC}^0; and xAUC1\mathrm{xAUC}^1 or xAUC0\mathrm{xAUC}^0 parity. We characterise their estimands, relate them to the decomposition of overall AUC (into within- and cross-group components), and critically appraise them. We then illustrate their behaviour using simulations based on the EuroSCORE II, a clinical prediction model for in-hospital mortality. We recommend reporting an AUC matrix, containing the overall AUC and all within- and cross-group AUC components, alongside population characteristics. When fairness metrics are needed, we recommend reporting the within-group AUC parity, with cross-group AUC parity providing supplementary information but requiring caution due to its potential conflict with calibration. Metrics involving xAUC1\mathrm{xAUC}^1 and xAUC0\mathrm{xAUC}^0 have merit, summarising within- and cross-group AUCs into single values, but their interpretation is non-trivial, and they should be used with caution. Gap-to-overall AUC, equity-scaled AUC, and minimum-based metrics compare quantities that should not be compared and it is unclear how to operationalise them, making them not fit for purpose and generally not recommended.